CardiaCare is a clinical stage Digital Therapeutic company has developed the world’s first closed loop wearable for non-invasive treatment of Atrial Fibrillation and other cardiac arrhythmias. Providing a non-invasive, nerve stimulation treatment with continuous monitoring and AI based alerts capabilities, CardiaCare’s device is the only platform that enables complete remote patient management and personalized treatment.
The device stems from many years of treatment of real-world patients and integrates know how and innovation from diverse disciplines. CardiaCare has a functional prototype and successfully completed a FIM study. Multi-National RCT's are currently underway.
Cumulative Funding Raised Over Time ($)
Employees Over Time
CardiaCare Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
Sep 18, 2023
www.prnewswire.com
CardiaCare Completes Seed Extension Raise to Support Clinical Pilot Studies
#Investment #Expand
May 9, 2023
www.massdevice.com
CardiaCare names Ken Nelson as chair of its board
#Management Changes
Dec 15, 2022
www.prnewswire.com
CardiaCare Announces Licensing and Distribution Agreement to Commercialize its Digital Neuromodulation Wearable for Non-invasive Atrial Fibrillation Treatment
#Partners
Dec 16, 2019
www.prnewswire.com
CardiaCare Awarded First Prize at the Innovation in Cardiovascular Interventions (ICI) Technology Parade in Tel Aviv, Israel
CardiaCare Completes Seed Extension Raise to Support Clinical Pilot Studies
#Investment #Expand
May 9, 2023
www.massdevice.com
CardiaCare names Ken Nelson as chair of its board
#Management Changes
Dec 15, 2022
www.prnewswire.com
CardiaCare Announces Licensing and Distribution Agreement to Commercialize its Digital Neuromodulation Wearable for Non-invasive Atrial Fibrillation Treatment
#Partners
Dec 16, 2019
www.prnewswire.com
CardiaCare Awarded First Prize at the Innovation in Cardiovascular Interventions (ICI) Technology Parade in Tel Aviv, Israel